- Drug Pipelines
- February 2018
- 19 Pages
Global
From €9507EUR$10,000USD£7,986GBP
- Report
- November 2024
- 108 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- July 2024
- 95 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Report
- January 2022
- 80 Pages
Africa
From €1901EUR$2,000USD£1,597GBP
- Report
- January 2022
- 40 Pages
Brazil
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
China
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
France
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Germany
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Ireland
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Japan
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Russia
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
South Korea
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
United States
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €1426EUR$1,500USD£1,198GBP
- Report
- March 2024
- 132 Pages
Global
From €903EUR$950USD£759GBP
- Report
- November 2023
- 215 Pages
China
From €3803EUR$4,000USD£3,195GBP
- Report
- November 2023
- 109 Pages
China
From €1711EUR$1,800USD£1,438GBP
- Report
- November 2021
- 284 Pages
Global
From €2852EUR$3,000USD£2,396GBP

The ACE Inhibitor market is a segment of the pharmaceutical industry that focuses on drugs used to treat high blood pressure, heart failure, and other cardiovascular diseases. ACE inhibitors are a type of medication that works by blocking the action of an enzyme called angiotensin-converting enzyme (ACE). This enzyme is responsible for producing a hormone called angiotensin II, which can cause blood vessels to narrow and increase blood pressure. By blocking the action of ACE, ACE inhibitors can help reduce blood pressure and improve the symptoms of heart failure.
ACE inhibitors are typically prescribed in combination with other medications, such as diuretics, beta-blockers, and calcium channel blockers. They are also used to treat other conditions, such as kidney disease, diabetes, and migraines.
Some companies in the ACE Inhibitor market include Pfizer, Merck, Novartis, Sanofi, and AstraZeneca. Show Less Read more